Novo Nordisk
NVO
#78
Rank
A$323.07 B
Marketcap
A$72.71
Share price
1.01%
Change (1 day)
-55.48%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): A$32.58 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are A$47.21 Billion. In 2024 the company made an earning of A$28.61 Billion, an increase over its 2023 earnings that were of A$23.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$32.58 B13.89%
2024 A$28.61 B22.84%
2023 A$23.29 B57.81%
2022 A$14.76 B5.24%
2021 A$14.02 B12.38%
2020 A$12.48 B13.11%
2019 A$11.03 B-3.45%
2018 A$11.42 B1.88%
2017 A$11.21 B4.3%
2016 A$10.75 B10.32%
2015 A$9.74 B7.47%
2014 A$9.07 B3.4%
2013 A$8.77 B19.09%
2012 A$7.36 B15.58%
2011 A$6.37 B16.58%
2010 A$5.46 B25.66%
2009 A$4.35 B10.68%
2008 A$3.93 B55.82%
2007 A$2.52 B7.02%
2006 A$2.35 B19.05%
2005 A$1.98 B10.55%
2004 A$1.79 B
2002 A$1.24 B-14.39%
2001 A$1.45 B-52.82%
2000 A$3.09 B250%
1999 A$0.88 B31.21%
1998 A$0.67 B34.31%
1997 A$0.50 B11.46%
1996 A$0.44 B9.03%
1995 A$0.41 B-3.15%
1994 A$0.42 B-0.67%
1993 A$0.42 B45.38%
1992 A$0.29 B-13.81%
1991 A$0.34 B37.12%
1990 A$0.24 B-0.79%
1989 A$0.25 B26.2%
1988 A$0.19 B24.97%
1987 A$0.15 B-0.9%
1986 A$0.16 B-7.78%
1985 A$0.17 B24.87%
1984 A$0.13 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$17.91 B-43.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$34.02 B 7.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.14 B-61.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$13.75 B-56.34%๐Ÿ‡ซ๐Ÿ‡ท France